ALPS Medical Breakthroughs ETF
SBIO
SBIO
28 hedge funds and large institutions have $19.2M invested in ALPS Medical Breakthroughs ETF in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 26 → 28 (+2)
0.14% more ownership
Funds ownership: 14.55% → 14.69% (+0.14%)
Holders
28
Holding in Top 10
–
Calls
$703K
Puts
$530K
Top Buyers
| 1 | +$2.62M | |
| 2 | +$509K | |
| 3 | +$353K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$347K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$224K |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$622K | |
| 3 | -$479K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$30.7K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$26K |